4DMedical Limited (ASX: 4DX)
Australia
· Delayed Price · Currency is AUD
0.455
+0.005 (1.11%)
Nov 22, 2024, 4:10 PM AEST
4DMedical Revenue
In the fiscal year ending June 30, 2024, 4DMedical had annual revenue of 3.75M AUD with 422.45% growth. 4DMedical had revenue of 2.96M in the half year ending June 30, 2024, with 229.93% growth.
Revenue
3.75M
Revenue Growth
+422.45%
P/S Ratio
44.90
Revenue / Employee
25.89K
Employees
145
Market Cap
186.79M
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Jun 30, 2024 | 3.75M | 3.04M | 422.45% |
Jun 30, 2023 | 718.58K | -335.72K | -31.84% |
Jun 30, 2022 | 1.05M | 837.32K | 385.90% |
Jun 30, 2021 | 216.98K | -1.02M | -82.40% |
Jun 30, 2020 | 1.23M | 537.50K | 77.34% |
Jun 30, 2019 | Pro | Pro | Pro |
Jun 30, 2018 | Pro | Pro | Pro |
Jun 30, 2017 | Pro | Pro | Pro |
Dec 31, 2015 | Pro | Pro | Pro |
Dec 31, 2014 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
CSL Limited | 22.18B |
ResMed Inc. | 6.93B |
Pro Medicus Limited | 161.50M |
Fisher & Paykel Healthcare Corporation Limited | 1.60B |
Cochlear Limited | 2.24B |
Sonic Healthcare Limited | 8.97B |
Ramsay Health Care Limited | 16.66B |
Telix Pharmaceuticals Limited | 645.68M |